The FDA is pushing to make more new and innovated medical devices available for patients in the U.S. Computational modeling is an important tool to reduce the burdens of pre-market device evaluations. In addition simulations can open the way for more personalized medicine and help FDA evaluate innovative emerging technologies.

During this webinar, we will discuss:

• FDA’s published perspectives on how simulations can help with regulatory approval.

• Types of simulations commonly used in FDA approvals

• Examples and demos of simulations in Ansys